Shin Nippon Biomedical Laboratories, Ltd. (OTCMKTS:SBLOF) Sees Significant Decrease in Short Interest

Shin Nippon Biomedical Laboratories, Ltd. (OTCMKTS:SBLOF) was the recipient of a significant decrease in short interest during the month of March. As of March 15th, there was short interest totalling 24,900 shares, a decrease of 16.4% from the February 28th total of 29,800 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is currently 249.0 days.

Shin Nippon Biomedical Laboratories Stock Performance

OTCMKTS SBLOF opened at $9.51 on Thursday. Shin Nippon Biomedical Laboratories has a fifty-two week low of $9.51 and a fifty-two week high of $9.82. The stock’s 50-day moving average is $9.70 and its two-hundred day moving average is $12.38.

Shin Nippon Biomedical Laboratories Company Profile

Shin Nippon Biomedical Laboratories, Ltd., a contract research organization, engages in the transactional research and medipolis businesses in Japan and internationally. It offers non-clinical studies, including single/repeated dose toxicity studies, antigenicity studies, skin sensitization studies, genotoxicity studies, carcinogenicity studies, local irritation studies, inhalation toxicity studies, TK studies, characteristic studies, stability studies, dependence studies, reproductive and developmental toxicity studies, safety pharmacological studies, and pharmacokinetic studies.